Cullen/Frost Bankers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-168
Closed -$9.1K 1463
2025
Q3
$9.1K Sell
168
-129
-43% -$7.38K ﹤0.01% 1090
2025
Q2
$16.3K Buy
297
+147
+98% +$8.66K ﹤0.01% 951
2025
Q1
$10.6K Buy
150
+67
+81% +$4.51K ﹤0.01% 936
2024
Q4
$5.46K Buy
83
+70
+538% +$4.69K ﹤0.01% 984
2024
Q3
$914 Hold
13
﹤0.01% 1175
2024
Q2
$1.07K Buy
+13
New +$1.08K ﹤0.01% 1180
2023
Q2
Sell
-4
Closed -$389 1142
2023
Q1
$389 Hold
4
﹤0.01% 1174
2022
Q4
$414 Hold
4
﹤0.01% 1086
2022
Q3
$0 Buy
+4
New +$356 ﹤0.01% 1143
2020
Q4
Sell
-18
Closed -$1K 1071
2020
Q3
$1K Buy
+18
New +$1.82K ﹤0.01% 1061
2020
Q2
Sell
-115
Closed -$10K 1095
2020
Q1
$10K Sell
115
-20
-15% -$1.72K ﹤0.01% 719
2019
Q4
$11K Sell
135
-126
-48% -$9.52K ﹤0.01% 880
2019
Q3
$18K Buy
261
+250
+2,273% +$19.3K ﹤0.01% 740
2019
Q2
$1K Sell
11
-41
-79% -$3.51K ﹤0.01% 982
2019
Q1
$5K Buy
+52
New +$4.82K ﹤0.01% 802

Other funds holding BMRN